These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12197456)

  • 1. Lamotrigine as an augmentation agent in treatment-resistant depression.
    Barbee JG; Jamhour NJ
    J Clin Psychiatry; 2002 Aug; 63(8):737-41. PubMed ID: 12197456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
    Maina G; Albert U; Rosso G; Bogetto F
    J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine augmentation in unipolar depression.
    Rocha FL; Hara C
    Int Clin Psychopharmacol; 2003 Mar; 18(2):97-9. PubMed ID: 12598821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
    Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
    J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
    Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L; Berk M; Vorster M
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open study of lamotrigine in refractory bipolar depression.
    Kusumakar V; Yatham LN
    Psychiatry Res; 1997 Sep; 72(2):145-8. PubMed ID: 9335206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine in rapid-cycling bipolar disorder.
    Fatemi SH; Rapport DJ; Calabrese JR; Thuras P
    J Clin Psychiatry; 1997 Dec; 58(12):522-7. PubMed ID: 9448654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting.
    Ginsberg LD
    CNS Spectr; 2006 May; 11(5):376-82. PubMed ID: 16641842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
    Calabrese JR; Suppes T; Bowden CL; Sachs GS; Swann AC; McElroy SL; Kusumakar V; Ascher JA; Earl NL; Greene PL; Monaghan ET
    J Clin Psychiatry; 2000 Nov; 61(11):841-50. PubMed ID: 11105737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression.
    Chang K; Saxena K; Howe M
    J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):298-304. PubMed ID: 16540814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.
    Pinto OC; Akiskal HS
    J Affect Disord; 1998 Dec; 51(3):333-43. PubMed ID: 10333987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.